Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences
EQS-News: Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences
EQS-News: Sernova to Participate in Upcoming Roth and Oppenheimer Investor Conferences
Katya Kruglova to join Sonova’s Management Board as GVP Human Resources & Communications
Katya Kruglova to join Sonova’s Management Board as GVP Human Resources & Communications
Katya Kruglova to join Sonova’s Management Board as GVP Human Resources & Communications
Chemed Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference:
Chemed Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 33rd Annual Healthcare Conference on Tuesday, March 14, 2023, at approximately 1:20 p.m

Agilent Reports First-Quarter Fiscal Year 2023 Financial Results:
Agilent Reports First-Quarter Fiscal Year 2023 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.76 billion for the first quarter ended January 31, 2023, an increase of 5% compared to the first quarter of 2022 and up 10% on a

Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: MediClin AG: Disclosure of the preliminary figures of the 2022 financial year
EQS-News: MediClin AG: Disclosure of the preliminary figures of the 2022 financial year
EQS-News: MediClin AG: Disclosure of the preliminary figures of the 2022 financial year
Acadia Healthcare Reports Fourth Quarter 2022 Results: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Reports Fourth Quarter 2022 Results


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2022.



Fourth Quarter Highlights




  • Revenue totaled $675.3

Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler: https://www.flatex.at/fileadmin/dateien_flatex/images/logos/logo-claim_flatex-at_positiv_rgb.png
Agilent Announces Bravo NGS Automated Liquid Handling Platform with On-Deck Thermal Cycler


Agilent Technologies Inc. (NYSE: A) today announced the release of an on-deck thermal cycler (ODTC) that integrates with the Agilent Bravo NGS automated liquid handling platform. The optional ODTC

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Inogen Announces Fourth Quarter and Full Year 2022 Financial Results: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen Announces Fourth Quarter and Full Year 2022 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the

Inogen to Provide Strategy Update on February 27, 2023: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen to Provide Strategy Update on February 27, 2023


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will host a conference call on Monday

Chemed Reports Fourth-Quarter 2022 Results:
Chemed Reports Fourth-Quarter 2022 Results


Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Dexcom Announces Upcoming Conference Presentations: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:




  • Sean Christensen, Vice President, Finance and

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Agilent Announces Cash Dividend of 22.5 Cents Per Share:
Agilent Announces Cash Dividend of 22.5 Cents Per Share


Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 22.5 cents per share of common stock will be paid on April 26, 2023, to all shareholders of record as of the close of

Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions:
Agilent Inspires at SLAS2023, Highlighting Innovative Automated Workflow Solutions


Agilent Technologies Inc. (NYSE: A) announced today that it will highlight a suite of automated laboratory workflow solutions at the SLAS2023 International Conference and Exhibition held February

Premier Inc. Acquires 100 Top Hospitals® Program: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. Acquires 100 Top Hospitals® Program


Premier Inc. (NASDAQ: PINC) acquired the 100 Top Hospitals® program from Merative (formerly IBM Watson Health). The program will be integrated within PINC AI, Premier’s technology and services

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023.

Dexcom stellt Genauigkeit, Unkompliziertheit und Konnektivität des CGM-Portfolios auf der ATTD Conference in den Blickpunkt, da Zugang zu CGM weltweit zunimmt: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom stellt Genauigkeit, Unkompliziertheit und Konnektivität des CGM-Portfolios auf der ATTD Conference in den Blickpunkt, da Zugang zu CGM weltweit zunimmt


DexCom, Inc. (NASDAQ: DXCM), der weltweit führende Anbieter im Bereich der kontinuierlichen Blutzuckermessung (CGM) in Echtzeit für Menschen mit Diabetes mellitus, wird die Leistungskraft seines

Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally


DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase the strength of its CGM portfolio and unveil new clinical and